These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2082231)

  • 1. Combination of recombinant interferon alpha-2A and vinblastine in advanced renal cell cancer.
    Schuster D; Schneider G; Ade N; Heim ME
    Onkologie; 1990 Oct; 13(5):359-62. PubMed ID: 2082231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of recombinant interferon alpha-2a and vinblastine in advanced renal cell carcinoma.
    Schornagel JH; Verweij J; ten Bokkel Huinink WW; Klijn JG; de Mulder PH; Debruyne FM; van Deijk WA; Roozendaal K; Kok TC; Veenhof KH
    J Urol; 1989 Aug; 142(2 Pt 1):253-6. PubMed ID: 2746739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined interferon and vinblastine treatment of advanced melanoma and renal cell cancer.
    Kellokumpu-Lehtinen P; Nordman E
    Cancer Detect Prev; 1988; 12(1-6):523-9. PubMed ID: 3180144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a role for adjuvant immunochemotherapy after radical nephrectomy in pT2-3N0M0 renal cell carcinoma?
    Migliari R; Muscas G; Solinas A; Melis M; Ionta MT; Massidda B; Usai E
    J Chemother; 1995 Jun; 7(3):240-5. PubMed ID: 7562021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant alpha-2a interferon plus vinblastine in the treatment of metastatic renal cell carcinoma.
    Sertoli MR; Brunetti I; Ardizzoni A; Falcone A; Guarneri D; Boccardo F; Martorana G; Curotto A; Sicignano A; Rosso R
    Am J Clin Oncol; 1989 Feb; 12(1):43-5. PubMed ID: 2492141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination therapy with recombinant interferon alpha-21 (rIFN alpha 2a) and recombinant interleukin 2 (rIL-2) in metastatic renal cell cancer].
    Jurincic-Winkler C; Horlbeck R; Klippel KF
    Wien Klin Wochenschr; 1993; 105(10):271-6. PubMed ID: 8517056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of immunochemotherapy on survival of patients with metastatic renal cell carcinoma. A retrospective study comparing interferon-alpha-2a/vinblastine versus interferon-alpha-2a/interleukin-2/5-fluorouracil].
    May M; Helke C; Bock M; Hoschke B
    Urologe A; 2004 Sep; 43(9):1111-9. PubMed ID: 15232686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metastasizing kidney cancer. Experience with interferon alfa-2a and vinblastine].
    González Enguita C; Roncalés Badal A; Gil Sanz MJ; Martínez Bengoechea J; Tello Royloa C; Rioja Sanz LA
    Actas Urol Esp; 1990; 14(5):335-8. PubMed ID: 2288249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of metastatic kidney cancer with recombinant alpha-2 or gamma interferon. Results of 2 clinical phase II and III studies].
    Otto U; Schneider A; Denkhaus H; Conrad S
    Onkologie; 1988 Aug; 11(4):185-91. PubMed ID: 3141856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic renal cell cancer treated with recombinant alpha 2a interferon and vinblastine.
    Massidda B; Migliari R; Padovani A; Scarpa RM; Pellegrini P; Cortesi E; Usai E; Pellegrini A
    J Chemother; 1991 Dec; 3(6):387-9. PubMed ID: 1819623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant alpha-interferon and vinblastine in metastatic renal cell carcinoma: efficacy of low doses.
    Cetto GL; Franceschi T; Turrina G; Chiarion-Sileni V; Capelli MC; Bellini A; Paccagnella A; Bassetto MA; Molino AM; de Sandre G
    Semin Surg Oncol; 1988; 4(3):184-90. PubMed ID: 3055162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up.
    Minasian LM; Motzer RJ; Gluck L; Mazumdar M; Vlamis V; Krown SE
    J Clin Oncol; 1993 Jul; 11(7):1368-75. PubMed ID: 8315435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does vinblastine add to the potency of alpha interferon in the treatment of renal cell carcinoma?
    Merimsky O; Shnider BI; Chaitchik S
    Mol Biother; 1991 Mar; 3(1):34-7. PubMed ID: 2069758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An outpatient phase II study of subcutaneous interleukin-2 and interferon-alpha-2b in combination with intravenous vinblastine in metastatic renal cell cancer.
    Pectasides D; Varthalitis J; Kostopoulou M; Mylonakis A; Triantaphyllis D; Papadopoulou M; Dimitriadis M; Athanassiou A
    Oncology; 1998; 55(1):10-5. PubMed ID: 9428369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma.
    Fosså SD; de Garis ST; Heier MS; Flokkmann A; Lien HH; Salveson A; Moe B
    Cancer; 1986 Apr; 57(8 Suppl):1700-4. PubMed ID: 3948141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.
    Figlin RA; deKernion JB; Maldazys J; Sarna G
    Cancer Treat Rep; 1985 Mar; 69(3):263-7. PubMed ID: 3978656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medical treatment of metastatic cancer of the kidney with a combination of vinblastine and recombinant interferon alpha IIa. Result of a phase I-II trial].
    Jacqmin D; Bergerat JP; Dufour P; Bollack C; Prévot G; Jurascheck F; Bailly G; Degaris S; Oberling F
    J Urol (Paris); 1987; 93(8):463-6. PubMed ID: 3440838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the CD4+/CD8+ ratio predict the outcome of interferon-alpha therapy for renal cell carcinoma?
    Hernberg M; Muhonen T; Pyrhönen S
    Ann Oncol; 1997 Jan; 8(1):71-7. PubMed ID: 9093710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma.
    Ernstoff MS; Nair S; Bahnson RR; Miketic LM; Banner B; Gooding W; Day R; Whiteside T; Hakala T; Kirkwood JM
    J Clin Oncol; 1990 Oct; 8(10):1637-49. PubMed ID: 2120392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: results of a European multi-center phase III study.
    Fosså SD; Martinelli G; Otto U; Schneider G; Wander H; Oberling F; Bauer HW; Achtnicht U; Holdener EE
    Ann Oncol; 1992 Apr; 3(4):301-5. PubMed ID: 1390305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.